Mitsubishi Tanabe Pharma Canada
GPTKB entity
Statements (51)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:collaboratesWith |
Research Institutions
Healthcare_Professionals |
| gptkbp:employs |
Sales Representatives
Regulatory Specialists Pharmaceutical Scientists |
| gptkbp:engagesIn |
Community Outreach
Patient Support Programs |
| gptkbp:establishedIn |
2008
|
| gptkbp:focusesOn |
Research_and_Development
|
| gptkbp:hasFilm |
To be a leader in innovative healthcare solutions
|
| gptkbp:hasMission |
To improve the quality of life for patients
|
| gptkbp:hasPart |
Clinical Trials
Human Resources Information Technology Market Research Training and Development Business Development Product Development Quality Assurance Regulatory Affairs Legal Affairs Corporate Communications Sales and Marketing Medical Affairs Finance_Department Supply_Chain_Management |
| gptkbp:hasProductLine |
gptkb:Radicava
gptkb:Mitsubishi_Tanabe_Pharma's_Neurology_Products Mitsubishi_Tanabe_Pharma's_Diabetes_Products Mitsubishi_Tanabe_Pharma's_Immunology_Products |
| gptkbp:hasWebsite |
www.mt-pharma.ca
|
| gptkbp:headquarteredIn |
gptkb:Canada
|
| https://www.w3.org/2000/01/rdf-schema#label |
Mitsubishi Tanabe Pharma Canada
|
| gptkbp:isActiveIn |
Corporate_Social_Responsibility
|
| gptkbp:isInvolvedIn |
Patient Advocacy
Market Access Strategies Clinical_Research |
| gptkbp:isKnownFor |
Collaborative Research
Innovative Therapies Patient-Centric_Approach |
| gptkbp:isPartOf |
gptkb:Mitsubishi_Tanabe_Pharma_Group
|
| gptkbp:isRegulatedBy |
gptkb:FDA
gptkb:Health_Canada |
| gptkbp:offers |
Pharmaceutical_Products
|
| gptkbp:operatesIn |
gptkb:North_America
|
| gptkbp:parentCompany |
gptkb:Mitsubishi_Tanabe_Pharma_Corporation
|
| gptkbp:participatesIn |
Health_Canada_Programs
|
| gptkbp:specializesIn |
Immunology
Diabetes Neurology |